When we classified all the recipient/donor HLA-C alleles of the matched cohort according to the genotypic groups and investigated the clinical outcomes, we did not observe any impact on OS, acute and chronic GvHD and relapse (Supplementary Figure 10A-D) in univariable models. Here, HLA-C is linked to graft versus host disease.